Advancing the science of technical and therapeutic proteins

NorthX Biologics is at the forefront of technical and therapeutic protein development, playing a critical role in supporting the production of advanced therapies, including cell and gene therapies. With over three decades of expertise, NorthX provides scalable solutions from early-stage research to full-scale commercial production, driving innovation in the biopharmaceutical industry.

In our latest article, Eva-karin Gidlund, Ph.D., MBA, Chief Business Officer, explores:

  • NorthX’s expertise in both technical and therapeutic protein manufacturing
  • Our scalable production capabilities, from concept to commercialization
  • The company’s commitment to sustainability and eco-friendly operations in Sweden
  • Our cutting-edge Innovation Hub as a center for collaborative development

Ready to explore the future of protein production? Download the full article to learn how NorthX Biologics can help advance your biopharma projects.

Fill out the form to read more.

Read about our Privacy Policy

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn